相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。SGLT2 inhibitors: a focus on cardiac benefits and potential mechanisms
Maja Nikolic et al.
HEART FAILURE REVIEWS (2022)
Efficacy of Dapagliflozin on Renal Function and Outcomes in Patients With Heart Failure With Reduced Ejection Fraction Results of DAPA-HF
Pardeep S. Jhund et al.
CIRCULATION (2021)
Natriuretic Effect of Two Weeks of Dapagliflozin Treatment in Patients With Type 2 Diabetes and Preserved Kidney Function During Standardized Sodium Intake: Results of the DAPASALT Trial
Rosalie A. Scholtes et al.
DIABETES CARE (2021)
SGLT2-inhibitors; more than just glycosuria and diuresis
Amir Fathi et al.
HEART FAILURE REVIEWS (2021)
Sotagliflozin in Patients with Diabetes and Chronic Kidney Disease
Deepak L. Bhatt et al.
NEW ENGLAND JOURNAL OF MEDICINE (2021)
A kidney perspective on the mechanism of action of sodium glucose co-transporter 2 inhibitors
Taha Sen et al.
CELL METABOLISM (2021)
DAPA-CKD: Significant Victory for CKD with or without Diabetes
Ankit B. Patel et al.
TRENDS IN ENDOCRINOLOGY AND METABOLISM (2021)
Cardioprotection conferred by sodium-glucose cotransporter 2 inhibitors: a renal proximal tubule perspective
Danubia Silva dos Santos et al.
AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY (2020)
Effect of Empagliflozin on Erythropoietin Levels, Iron Stores, and Red Blood Cell Morphology in Patients With Type 2 Diabetes Mellitus and Coronary Artery Disease
C. David Mazer et al.
CIRCULATION (2020)
Sodium-glucose cotransporter 2 inhibitor Dapagliflozin attenuates diabetic cardiomyopathy
M. Arow et al.
CARDIOVASCULAR DIABETOLOGY (2020)
The Redox-Sensitive Na/K-ATPase Signaling in Uremic Cardiomyopathy
Jiang Liu et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
Comparison of the effects of insulin and SGLT2 inhibitor on the Renal Renin-Angiotensin system in type 1 diabetes mice
Kana N. Miyata et al.
DIABETES RESEARCH AND CLINICAL PRACTICE (2020)
Renal hemodynamic effects of sodium-glucose cotransporter 2 inhibitors in hyperfiltering people with type 1 diabetes and people with type 2 diabetes and normal kidney function
Erik J. M. van Bommel et al.
KIDNEY INTERNATIONAL (2020)
Central Role for Adipocyte Na,K-ATPase Oxidant Amplification Loop in the Pathogenesis of Experimental Uremic Cardiomyopathy (Publication with Expression of Concern. See vol. 33, pg. 1957, 2022)
Komal Sodhi et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2020)
Sodium-Glucose Co-Transporter 2 Inhibitors Correct Metabolic Maladaptation of Proximal Tubular Epithelial Cells in High-Glucose Conditions
Kohsuke Shirakawa et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
Cardiovascular and Renal Outcomes with Empagliflozin in Heart Failure
Milton Packer et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Dapagliflozin in Patients with Chronic Kidney Disease
Hiddo J. L. Heerspink et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Effects of dapagliflozin on major adverse kidney and cardiovascular events in patients with diabetic and non-diabetic chronic kidney disease: a prespecified analysis from the DAPA-CKD trial
David C Wheeler et al.
Lancet Diabetes & Endocrinology (2020)
Stress Signal Regulation by Na/K-ATPase As a New Approach to Promote Physiological Revascularization in a Mouse Model of Ischemic Retinopathy
Jiayan Wang et al.
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE (2020)
A role for tubular Na+/H+ exchanger NHE3 in the natriuretic effect of the SGLT2 inhibitor empagliflozin
Akira Onishi et al.
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2020)
Mechanisms of Cardiovascular Benefits of Sodium Glucose Co-Transporter 2 (SGLT2) Inhibitors A State-of-the-Art Review
Gary D. Lopaschuk et al.
JACC-BASIC TO TRANSLATIONAL SCIENCE (2020)
SGLT2 inhibition with empagliflozin attenuates myocardial oxidative stress and fibrosis in diabetic mice heart
Chenguang Li et al.
CARDIOVASCULAR DIABETOLOGY (2019)
Beneficial effects of SGLT2 inhibitors on fatty liver in type 2 diabetes: A common comorbidity associated with severe complications
A. J. Scheen
DIABETES & METABOLISM (2019)
Effect of SGLT2 inhibitors on cardiovascular, renal and safety outcomes in patients with type 2 diabetes mellitus and chronic kidney disease: A systematic review and meta-analysis
Tadashi Toyama et al.
DIABETES OBESITY & METABOLISM (2019)
SGLT2 inhibitors and cardioprotection: a matter of debate and multiple hypotheses
Theodosios D. Filippatos et al.
POSTGRADUATE MEDICINE (2019)
Effect of SGLT2 inhibitors on body composition, fluid status and renin-angiotensin-aldosterone system in type 2 diabetes: a prospective study using bioimpedance spectroscopy
Anja Schork et al.
CARDIOVASCULAR DIABETOLOGY (2019)
Canagliflozin reduces inflammation and fibrosis biomarkers: a potential mechanism of action for beneficial effects of SGLT2 inhibitors in diabetic kidney disease
Hiddo J. L. Heerspink et al.
DIABETOLOGIA (2019)
Canagliflozin and Renal Outcomes in Type 2 Diabetes and Nephropathy
V. Perkovic et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
Evaluation of Glomerular Hemodynamic Function by Empagliflozin in Diabetic Mice Using In Vivo Imaging
Kengo Kidokoro et al.
CIRCULATION (2019)
Metabolic Syndrome and Salt-Sensitive Hypertension in Polygenic Obese TALLYHO/JngJ Mice: Role of Na/K-ATPase Signaling
Yanling Yan et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
被撤回的出版物: The Adipocyte Na/K-ATPase Oxidant Amplification Loop is the Central Regulator of Western Diet-Induced Obesity and Associated Comorbidities (Retracted article. See vol. 12, 2022)
Rebecca D. Pratt et al.
SCIENTIFIC REPORTS (2019)
SGLT2 Inhibitors: A Review of Their Antidiabetic and Cardioprotective Effects
Anastasios Tentolouris et al.
INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH (2019)
Effects of dapagliflozin on development and progression of kidney disease in patients with type 2 diabetes: an analysis from the DECLARE-TIMI 58 randomised trial
Ofri Mosenzon et al.
LANCET DIABETES & ENDOCRINOLOGY (2019)
Monoclonal Antibody to Marinobufagenin Downregulates TGFβ Profibrotic Signaling in Left Ventricle and Kidney and Reduces Tissue Remodeling in Salt-Sensitive Hypertension
Yongqing Zhang et al.
JOURNAL OF THE AMERICAN HEART ASSOCIATION (2019)
Renal Effects of Sodium-Glucose Co-Transporter Inhibitors
Scott C. Thomson et al.
AMERICAN JOURNAL OF CARDIOLOGY (2019)
Twenty-Four-Hour Blood Pressure-Lowering Effect of a Sodium-Glucose Cotransporter 2 Inhibitor in Patients With Diabetes and Uncontrolled Nocturnal Hypertension Results From the Randomized, Placebo-Controlled SACRA Study
Kazuomi Kario et al.
CIRCULATION (2019)
Treating oxidative stress in heart failure: past, present and future
Atze van der Pol et al.
EUROPEAN JOURNAL OF HEART FAILURE (2019)
Evolving concepts in the pathogenesis of uraemic cardiomyopathy
Xiaoliang Wang et al.
NATURE REVIEWS NEPHROLOGY (2019)
Dapagliflozin and Cardiovascular Outcomes in Type 2 Diabetes
S. D. Wiviott et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
SGLT2 Inhibitor, Canagliflozin, Attenuates Myocardial Infarction in the Diabetic and Nondiabetic Heart
Ven G. Lim et al.
JACC-BASIC TO TRANSLATIONAL SCIENCE (2019)
Prompt apoptotic response to high glucose in SGLT-expressing renal cells
Linnea M. Nilsson et al.
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2019)
Effect of renal tubule-specific knockdown of the Na+/H+ exchanger NHE3 in Akita diabetic mice
Akira Onishi et al.
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2019)
Amelioration of diabetic nephropathy by SGLT2 inhibitors independent of its glucose-lowering effect: A possible role of SGLT2 in mesangial cells
Toshinobu Maki et al.
SCIENTIFIC REPORTS (2019)
Reactive oxygen species signalling in the diabetic heart: emerging prospect for therapeutic targeting
Adam J. Wilson et al.
HEART (2018)
Pathways to Cardiorenal Complications in Type 2 Diabetes Mellitus: A Need to Rethink
Naveed Sattar et al.
CIRCULATION (2018)
Effects of the SGLT-2 inhibitor dapagliflozin on glomerular and tubular injury markers
Claire C. J. Dekkers et al.
DIABETES OBESITY & METABOLISM (2018)
Na/K-ATPase signaling mediates miR-29b-3p regulation and cardiac fibrosis formation in mice with chronic kidney disease
Christopher A. Drummond et al.
PLOS ONE (2018)
High Basolateral Glucose Increases Sodium-Glucose Cotransporter 2 and Reduces Sirtuin-1 in Renal Tubules through Glucose Transporter-2 Detection
Hiroyuki Umino et al.
SCIENTIFIC REPORTS (2018)
Canagliflozin inhibits interleukin-1 beta-stimulated cytokine and chemokine secretion in vascular endothelial cells by AMP-activated protein kinase-dependent and -independent mechanisms
Sarah J. Mancini et al.
SCIENTIFIC REPORTS (2018)
被撤回的出版物: The Na/K-ATPase Oxidant Amplification Loop Regulates Aging (Retracted article. See vol. 12, 2022)
Komal Sodhi et al.
SCIENTIFIC REPORTS (2018)
SGLT2 inhibitors: hypotheses on the mechanism of cardiovascular protection
Robert M. Bell et al.
LANCET DIABETES & ENDOCRINOLOGY (2018)
The Na/K-ATPase Signaling: From Specific Ligands to General Reactive Oxygen Species
Rebecca D. Pratt et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2018)
Improvement in Cardiovascular Outcomes With Empagliflozin Is Independent of Glycemic Control
Silvio E. Inzucchi et al.
CIRCULATION (2018)
Proximal Tubule-Specific Deletion of the NHE3 (Na+/H+ Exchanger 3) Promotes the Pressure-Natriuresis Response and Lowers Blood Pressure in Mice
Xiao C. Li et al.
HYPERTENSION (2018)
Empagliflozin and Kidney Function Decline in Patients with Type 2 Diabetes: A Slope Analysis from the EMPA-REG OUTCOME Trial
Christoph Wanner et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2018)
Direct Cardiac Actions of Sodium Glucose Cotransporter 2 Inhibitors Target Pathogenic Mechanisms Underlying Heart Failure in Diabetic Patients
Laween Uthman et al.
FRONTIERS IN PHYSIOLOGY (2018)
Evaluation of renal and cardiovascular protection mechanisms of SGLT2 inhibitors: model-based analysis of clinical data
K. Melissa Hallow et al.
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2018)
Class effects of SGLT2 inhibitors in mouse cardiomyocytes and hearts: inhibition of Na+/H+ exchanger, lowering of cytosolic Na+ and vasodilation
Laween Uthman et al.
DIABETOLOGIA (2018)
Cardiac effects of SGLT2 inhibitors: the sodium hypothesis
Edoardo Bertero et al.
CARDIOVASCULAR RESEARCH (2018)
Recent novel approaches to limit oxidative stress and inflammation in diabetic complications
Raelene J. Pickering et al.
CLINICAL & TRANSLATIONAL IMMUNOLOGY (2018)
Targeting renal glucose reabsorption to treat hyperglycaemia: the pleiotropic effects of SGLT2 inhibition
Volker Vallon et al.
DIABETOLOGIA (2017)
Empagliflozin decreases myocardial cytoplasmic Na+ through inhibition of the cardiac Na+/H+ exchanger in rats and rabbits
Antonius Baartscheer et al.
DIABETOLOGIA (2017)
Sodium glucose cotransporter 2 in mesangial cells and retinal pericytes and its implications for diabetic nephropathy and retinopathy
Masarori Wakisaka et al.
GLYCOBIOLOGY (2017)
Canagliflozin and Cardiovascular and Renal Events in Type 2 Diabetes
Bruce Neal et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
A Mouse 5/6th Nephrectomy Model That Induces Experimental Uremic Cardiomyopathy
Xiaoliang Wang et al.
JOVE-JOURNAL OF VISUALIZED EXPERIMENTS (2017)
A Practical Approach to Hypertension Management in Diabetes
Altamash Shaikh
DIABETES THERAPY (2017)
A Practical Approach to Hypertension Management in Diabetes
Altamash Shaikh
DIABETES THERAPY (2017)
被撤回的出版物: pNaKtide Attenuates Steatohepatitis and Atherosclerosis by Blocking Na/K-ATPase/ROS Amplification in C57BI6 and ApoE Knockout Mice Fed a Western Diet (Retracted article. See vol. 12, 2022)
Komal Sodhi et al.
SCIENTIFIC REPORTS (2017)
Sodium Glucose Cotransporter-2 Inhibition in Heart Failure Potential Mechanisms, Clinical Applications, and Summary of Clinical Trials
Yuliya Lytvyn et al.
CIRCULATION (2017)
Activation and Inhibition of Sodium-Hydrogen Exchanger Is a Mechanism That Links the Pathophysiology and Treatment of Diabetes Mellitus With That of Heart Failure
Milton Packer
CIRCULATION (2017)
Lower Risk of Heart Failure and Death in Patients Initiated on Sodium-Glucose Cotransporter-2 Inhibitors Versus Other Glucose-Lowering Drugs The CVD-REAL Study (Comparative Effectiveness of Cardiovascular Outcomes in New Users of Sodium-Glucose Cotransporter-2 Inhibitors)
Mikhail Kosiborod et al.
CIRCULATION (2017)
Empagliflozin Improves Left Ventricular Diastolic Dysfunction in a Genetic Model of Type 2 Diabetes
Nadjib Hammoudi et al.
CARDIOVASCULAR DRUGS AND THERAPY (2017)
Differential Effects of Dapagliflozin on Cardiovascular Risk Factors at Varying Degrees of Renal Function
Sergei Petrykiv et al.
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2017)
SGLT-2 Inhibition with Dapagliflozin Reduces the Activation of the Nlrp3/ASC Inflammasome and Attenuates the Development of Diabetic Cardiomyopathy in Mice with Type 2 Diabetes. Further Augmentation of the Effects with Saxagliptin, a DPP4 Inhibitor
Yumei Ye et al.
CARDIOVASCULAR DRUGS AND THERAPY (2017)
The Sodium-Glucose Cotransporter 2 Inhibitor Dapagliflozin Prevents Cardiomyopathy in a Diabetic Lipodystrophic Mouse Model
Michael Joubert et al.
DIABETES (2017)
Empagliflozin lessened cardiac injury and reduced visceral adipocyte hypertrophy in prediabetic rats with metabolic syndrome
Hiroaki Kusaka et al.
CARDIOVASCULAR DIABETOLOGY (2016)
Sodium Glucose Cotransporter 2 Inhibitors in the Treatment of Diabetes Mellitus: Cardiovascular and Kidney Effects, Potential Mechanisms, and Clinical Applications
Hiddo J. L. Heerspink et al.
CIRCULATION (2016)
Potential role of sodium glucose cotransporter 2 inhibitors in the treatment of hypertension
Ilkka Tikkanen et al.
CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION (2016)
CV Protection in the EMPA-REG OUTCOME Trial: A Thrifty Substrate Hypothesis
Ele Ferrannini et al.
DIABETES CARE (2016)
Prevention of apoptosis averts glomerular tubular disconnection and podocyte loss in proteinuric kidney disease
Ievgeniia Burlaka et al.
KIDNEY INTERNATIONAL (2016)
TGF-β: the master regulator of fibrosis
Xiao-ming Meng et al.
NATURE REVIEWS NEPHROLOGY (2016)
Empagliflozin and Progression of Kidney Disease in Type 2 Diabetes
Christoph Wanner et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
Na/K-ATPase signaling regulates collagen synthesis through microRNA-29b-3p in cardiac fibroblasts
Christopher A. Drummond et al.
PHYSIOLOGICAL GENOMICS (2016)
Sodium Glucose Cotransporter 2 (SGLT2) Plays as a Physiological Glucose Sensor and Regulates Cellular Contractility in Rat Mesangial Cells
Masanori Wakisaka et al.
PLOS ONE (2016)
Diabetes mellitus and oxidative stress-A concise review
Asmat Ullah et al.
SAUDI PHARMACEUTICAL JOURNAL (2016)
Rapamycin Attenuates Cardiac Fibrosis in Experimental Uremic Cardiomyopathy by Reducing Marinobufagenin Levels and Inhibiting Downstream Pro-Fibrotic Signaling
Steven T. Haller et al.
JOURNAL OF THE AMERICAN HEART ASSOCIATION (2016)
Attenuation of Na/K-ATPase Mediated Oxidant Amplification with pNaKtide Ameliorates Experimental Uremic Cardiomyopathy
Jiang Liu et al.
SCIENTIFIC REPORTS (2016)
Inhibition of SGLT2 alleviates diabetic nephropathy by suppressing high glucose-induced oxidative stress in type 1 diabetic mice
Takashi Hatanaka et al.
PHARMACOLOGY RESEARCH & PERSPECTIVES (2016)
NADPH Oxidase 4 Induces Cardiac Fibrosis and Hypertrophy Through Activating Akt/mTOR and NFκB Signaling Pathways
Qingwei David Zhao et al.
CIRCULATION (2015)
Acid-Base Homeostasis
L. Lee Hamm et al.
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2015)
Cardiometabolic Effects of a New Class of Antidiabetic Agents
Cyrus V. Desouza et al.
CLINICAL THERAPEUTICS (2015)
Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes
Bernard Zinman et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Insulin stimulates SGLT2-mediated tubular glucose absorption via oxidative stress generation
Nobutaka Nakamura et al.
DIABETOLOGY & METABOLIC SYNDROME (2015)
Intracellular Na+ Concentration ([Na+]i) Is Elevated in Diabetic Hearts Due to Enhanced Na+-Glucose Cotransport
Rebekah Lambert et al.
JOURNAL OF THE AMERICAN HEART ASSOCIATION (2015)
Expression of SGLT1 in Human Hearts and Impairment of Cardiac Glucose Uptake by Phlorizin during Ischemia-Reperfusion Injury in Mice
Yusuke Kashiwagi et al.
PLOS ONE (2015)
Reduction of Na/K-ATPase affects cardiac remodeling and increases c-kit cell abundance in partial nephrectomized mice
Christopher A. Drummond et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2014)
The effect of empagliflozin on arterial stiffness and heart rate variability in subjects with uncomplicated type 1 diabetes mellitus
David Z. I. Cherney et al.
CARDIOVASCULAR DIABETOLOGY (2014)
Glycemic control with empagliflozin, a novel selective SGLT2 inhibitor, ameliorates cardiovascular injury and cognitive dysfunction in obese and type 2 diabetic mice
Bowen Lin et al.
CARDIOVASCULAR DIABETOLOGY (2014)
Renal Hemodynamic Effect of Sodium-Glucose Cotransporter 2 Inhibition in Patients With Type 1 Diabetes Mellitus
David Z. I. Cherney et al.
CIRCULATION (2014)
Proximal Tubule Function and Response to Acidosis
Norman P. Curthoys et al.
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2014)
Effects of sodium-glucose co-transporter 2 inhibitors on blood pressure: A systematic review and meta-analysis
William L. Baker et al.
JOURNAL OF THE AMERICAN SOCIETY OF HYPERTENSION (2014)
Volume overload correlates with cardiovascular risk factors in patients with chronic kidney disease
Szu-Chun Hung et al.
KIDNEY INTERNATIONAL (2014)
N-acetylcysteine reduces oxidative stress, nuclear factor-κB activity and Cardiomyocyte apoptosis in heart failure
Xiao-Yan Wu et al.
MOLECULAR MEDICINE REPORTS (2014)
Long-Term Treatment with the Sodium Glucose Cotransporter 2 Inhibitor, Dapagliflozin, Ameliorates Glucose Homeostasis and Diabetic Nephropathy in db/db Mice
Naoto Terami et al.
PLOS ONE (2014)
Sodium-Glucose Cotransporter 2 Inhibitors for Type 2 Diabetes A Systematic Review and Meta-analysis
Despoina Vasilakou et al.
ANNALS OF INTERNAL MEDICINE (2013)
Determinants of kidney oxygen consumption and their relationship to tissue oxygen tension in diabetes and hypertension
Peter Hansell et al.
CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY (2013)
The Prevalence of Meeting A1C, Blood Pressure, and LDL Goals Among People With Diabetes, 1988-2010
Sarah Stark Casagrande et al.
DIABETES CARE (2013)
Efficacy and safety of canagliflozin in patients with type 2 diabetes mellitus inadequately controlled with metformin and sulphonylurea: a randomised trial
J. P. H. Wilding et al.
INTERNATIONAL JOURNAL OF CLINICAL PRACTICE (2013)
Involvement of Reactive Oxygen Species in a Feed-forward Mechanism of Na/K-ATPase-mediated Signaling Transduction
Yanling Yan et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2013)
Loss of NHE1 activity leads to reduced oxidative stress in heart and mitigates high-fat diet-induced myocardial stress
Vikram Prasad et al.
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2013)
Regulation of the cardiac Na+/H+ exchanger in health and disease
Shigeo Wakabayashi et al.
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2013)
Ouabain Protects against Shiga Toxin-Triggered Apoptosis by Reversing the Imbalance between Bax and Bcl-xL
Ievgeniia Burlaka et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2013)
Effects of SGLT2 Inhibition in Human Kidney Proximal Tubular Cells-Renoprotection in Diabetic Nephropathy?
Usha Panchapakesan et al.
PLOS ONE (2013)
Monoclonal Antibody Against Marinobufagenin Reverses Cardiac Fibrosis in Rats With Chronic Renal Failure
Steven T. Haller et al.
AMERICAN JOURNAL OF HYPERTENSION (2012)
Reduction of Na/K-ATPase Potentiates Marinobufagenin-induced Cardiac Dysfunction and Myocyte Apoptosis
Changxuan Liu et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2012)
Glomerular hyperfiltration: definitions, mechanisms and clinical implications
Imed Helal et al.
NATURE REVIEWS NEPHROLOGY (2012)
Can We Target Tubular Damage to Prevent Renal Function Decline in Diabetes?
Joseph V. Bonventre
SEMINARS IN NEPHROLOGY (2012)
Signaling through the Na/K-ATPase: implications for cardiac fibrosis
Joseph I. Shapiro et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2011)
Na/K-ATPase Mimetic pNaKtide Peptide Inhibits the Growth of Human Cancer Cells
Zhichuan Li et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
Impairment of Na/K-ATPase Signaling in Renal Proximal Tubule Contributes to Dahl Salt-sensitive Hypertension
Jiang Liu et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
Structural insights into the high affinity binding of cardiotonic steroids to the Na+,K+-ATPase
Laure Yatime et al.
JOURNAL OF STRUCTURAL BIOLOGY (2011)
SGLT2 Mediates Glucose Reabsorption in the Early Proximal Tubule
Volker Vallon et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2011)
Glucose dynamics and mechanistic implications of SGLT2 inhibitors in animals and humans
James F. List et al.
KIDNEY INTERNATIONAL (2011)
Endogenous cardiotonic steroids in chronic renal failure
Elena V. Kolmakova et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2011)
Biology of Human Sodium Glucose Transporters
Ernest M. Wright et al.
PHYSIOLOGICAL REVIEWS (2011)
Cell Signaling by Protein Carbonylation and Decarbonylation
Chi Ming Wong et al.
ANTIOXIDANTS & REDOX SIGNALING (2010)
Elevated Cytosolic Na+ Increases Mitochondrial Formation of Reactive Oxygen Species in Failing Cardiac Myocytes
Michael Kohlhaas et al.
CIRCULATION (2010)
Role of the kidney in normal glucose homeostasis and in the hyperglycaemia of diabetes mellitus: therapeutic implications
J. E. Gerich
DIABETIC MEDICINE (2010)
Is oxidative stress a therapeutic target in cardiovascular disease?
Thomas Muenzel et al.
EUROPEAN HEART JOURNAL (2010)
Ouabain protects against adverse developmental programming of the kidney
Juan Li et al.
NATURE COMMUNICATIONS (2010)
P-type ATPases as drug targets: Tools for medicine and science
Laure Yatime et al.
BIOCHIMICA ET BIOPHYSICA ACTA-BIOENERGETICS (2009)
SGLT1 is a novel cardiac glucose transporter that is perturbed in disease states
Sanjay K. Banerjee et al.
CARDIOVASCULAR RESEARCH (2009)
Transforming growth factor beta (TGF beta)-induced apoptosis The rise & fall of Bim
Sneha Ramesh et al.
CELL CYCLE (2009)
NaKtide, a Na/K-ATPase-derived Peptide Src Inhibitor, Antagonizes Ouabain-activated Signal Transduction in Cultured Cells
Zhichuan Li et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
Glucose Control and Vascular Complications in Veterans with Type 2 Diabetes
William Duckworth et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
The Na/K-ATPase/Src complex and cardiotonic steroid-activated protein kinase cascades
Zhichuan Li et al.
PFLUGERS ARCHIV-EUROPEAN JOURNAL OF PHYSIOLOGY (2009)
Endogenous Cardiotonic Steroids: Physiology, Pharmacology, and Novel Therapeutic Targets
A. Y. Bagrov et al.
PHARMACOLOGICAL REVIEWS (2009)
Marinobufagenin induces increases in procollagen expression in a process involving protein kinase C and Fli-1: implications for uremic cardiomyopathy
Jihad Elkareh et al.
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2009)
Regulation of apical NHE3 trafficking by ouabain-induced activation of the basolateral Na+-K+-ATPase receptor complex
Haiping Cai et al.
AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY (2008)
Altered Na+/Ca2+-exchanger activity due to downregulation of Na+/K+-ATPase α2-isoform in heart failure
Fredrik Swift et al.
CARDIOVASCULAR RESEARCH (2008)
Protein carbonylation as a novel mechanism in redox signaling
Chi Ming Wong et al.
CIRCULATION RESEARCH (2008)
Cardiorenal Syndrome
Claudio Ronco et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2008)
Ouabain-sensitive α1 Na,K-ATPase enhances natriuretic response to saline load
Elizabeth L. Loreaux et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2008)
Chronic hypoxia as a mechanism of progression of chronic kidney diseases: from hypothesis to novel therapeutics
Leon G. Fine et al.
KIDNEY INTERNATIONAL (2008)
Role of endogenous cardiotonic steroids in sodium homeostasis
Wilhelm Schoner et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2008)
Endogenous digitalis: pathophysiologic roles and therapeutic applications
Alexei Y. Bagrov et al.
NATURE CLINICAL PRACTICE NEPHROLOGY (2008)
Attenuation of interstitial fibrosis and tubular apoptosis in db/db transgenic mice overexpressing catalase in renal proximal tubular cells
Marie-Luise Brezniceanu et al.
DIABETES (2008)
Endogenous and exogenous cardiac glycosides: their roles in hypertension, salt metabolism, and cell growth
Wilhelm Schoner et al.
AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY (2007)
Oxidative stress and redox signalling in cardiac hypertrophy and heart failure
Mike Seddon et al.
HEART (2007)
Regulatory mechanisms of Na+/glucose cotransporters in renal proximal tubule cells
Y. J. Lee et al.
KIDNEY INTERNATIONAL (2007)
High prevalence of renal dysfunction and its impact on outcome in 118,465 patients hospitalized with acute decompensated heart failure: A report from the ADHERE database
J. Thomas Heywood et al.
JOURNAL OF CARDIAC FAILURE (2007)
Mechanical forces in diabetic kidney disease: A trigger for impaired glucose metabolism
Luigi Gnudi et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2007)
Involvement of endogenous ouabain-like compound in the cardiac hypertrophic process in vivo
Reka Skoumal et al.
LIFE SCIENCES (2007)
Ouabain induces cardiac remodeling in rats independent of blood pressure
Xing Jiang et al.
ACTA PHARMACOLOGICA SINICA (2007)
New roles for an old enzyme: Na,K-ATPase emerges as an interesting drug target
A. Aperia
JOURNAL OF INTERNAL MEDICINE (2007)
Marinobufagenin stimulates fibroblast collagen production and causes fibrosis in experimental uremic cardiomyopathy
Jihad Elkareh et al.
HYPERTENSION (2007)
Endogenous and exogenous cardiac glycosides and their mechanisms of action
Wilhelm Schoner et al.
AMERICAN JOURNAL OF CARDIOVASCULAR DRUGS (2007)
Active sugar transport in health and disease
E. M. Wright et al.
JOURNAL OF INTERNAL MEDICINE (2007)
Involvement of Na+/K+-ATPase in hydrogen peroxide-induced hypertrophy in cardiac myocytes
Lijun Liu et al.
FREE RADICAL BIOLOGY AND MEDICINE (2006)
The efficacy and safety of multivitamin and mineral supplement use to prevent cancer and chronic disease in adults: A systematic review for a National Institutes of Health State-of-the-Science Conference
Han-Yao Huang et al.
ANNALS OF INTERNAL MEDICINE (2006)
The Na,K-ATPase α4 isoform from humans has distinct enzymatic properties and is important for sperm motility
Gladis Sanchez et al.
MOLECULAR HUMAN REPRODUCTION (2006)
NADPH oxidase-dependent redox signalling in cardiac hypertrophy, remodelling and failure
Colin E. Murdoch et al.
CARDIOVASCULAR RESEARCH (2006)
Salt intake and depletion increase circulating levels of endogenous ouabain in normal men
P Manunta et al.
AMERICAN JOURNAL OF PHYSIOLOGY-REGULATORY INTEGRATIVE AND COMPARATIVE PHYSIOLOGY (2006)
Central role for the cardiotonic steroid marinobufagenin in the pathogenesis of experimental uremic cardiomyopathy
DJ Kennedy et al.
HYPERTENSION (2006)
Rostafuroxin:: an ouabain antagonist that corrects renal and vascular Na+-K+-ATPase alterations in ouabain and adducin-dependent hypertension
P Ferrari et al.
AMERICAN JOURNAL OF PHYSIOLOGY-REGULATORY INTEGRATIVE AND COMPARATIVE PHYSIOLOGY (2006)
Renal function as a predictor of outcome in a broad spectrum of patients with heart failure
HL Hillege et al.
CIRCULATION (2006)
Cardiac myocytes Ca2+ and Na+ regulation in normal and failing hearts
DM Bers et al.
JOURNAL OF PHARMACOLOGICAL SCIENCES (2006)
Glucose transporters in human renal proximal tubular cells isolated from the urine of patients with non-insulin-dependent diabetes
H Rahmoune et al.
DIABETES (2005)
The highly conserved cardiac glycoside binding site of Na,K-ATPase plays a role in blood pressure regulation
I Dostanic-Larson et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Brain ouabain stimulates peripheral marinobufagenin via angiotensin II signalling in NaCl-loaded Dahl-S rats
OV Fedorova et al.
JOURNAL OF HYPERTENSION (2005)
Salt loading induces redistribution of the plasmalemmal Na/K-ATPase in proximal tubule cells
SM Periyasamy et al.
KIDNEY INTERNATIONAL (2005)
Ouabain-induced endocytosis of the plasmalemmal Na/K-ATPase in LLC-PK1 cells requires caveolin-1
JA Liu et al.
KIDNEY INTERNATIONAL (2005)
Pathogenetic mechanisms of diabetic nephropathy
FP Schena et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2005)
The α2-isoform of Na-K-ATPase mediates ouabain-induced hypertension in mice and increased vascular contractility in vitro
I Dostanic et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2005)
A novel endogenous digitalis, telocinobufagin, exhibits elevated plasma levels in patients with terminal renal failure
Y Komiyama et al.
CLINICAL BIOCHEMISTRY (2005)
Chronic inhibition of Na+/H+-exchanger attenuates cardiac hypertrophy and prevents cellular remodeling in heart failure
A Baartscheer et al.
CARDIOVASCULAR RESEARCH (2005)
Reactive oxygen species, vascular oxidative stress, and redox signaling in hypertension - What is the clinical significance?
RM Touyz
HYPERTENSION (2004)
Organ hypertrophic signaling within caveolae membrane subdomains triggered by ouabain and antagonized by PST 2238
M Ferrandi et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Ouabain induces endocytosis of plasmalemmal Na/K-ATPase in LLC-PK1 cells by a clathrin-dependent mechanism
J Liu et al.
KIDNEY INTERNATIONAL (2004)
Attenuation of cardiac contractility in Na,K-ATPase α1 isoform-deficient hearts under reduced calcium conditions
AE Moseley et al.
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2004)
Role of sodium-calcium exchanger in modulating the action potential of ventricular myocytes from normal and failing hearts
AA Armoundas et al.
CIRCULATION RESEARCH (2003)
The Na, K-ATPase in the failing human heart
RHG Schwinger et al.
CARDIOVASCULAR RESEARCH (2003)
[Na+]i and the driving force of the Na+/Ca2+-exchanger in heart failure
A Baartscheer et al.
CARDIOVASCULAR RESEARCH (2003)
Increased Na+/H+-exchange activity is the cause of increased [Na+]i and underlies disturbed calcium handling in the rabbit pressure and volume overload heart failure model
A Baartscheer et al.
CARDIOVASCULAR RESEARCH (2003)
Longer term effects of ouabain on the contractility of rat isolated cardiomyocytes and on the expression of Ca and Na regulating proteins
J Müller-Ehmsen et al.
BASIC RESEARCH IN CARDIOLOGY (2003)
Involvement of mitogen-activated protein kinases and reactive oxygen species in the inotropic action of ouabain on cardiac myocytes. A potential role for mitochondrial K-ATP channels
J Tian et al.
MOLECULAR AND CELLULAR BIOCHEMISTRY (2003)
Effect of chronic renal failure on cardiac contractile function, calcium cycling, and gene expression of proteins important for calcium homeostasis in the rat
D Kennedy et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2003)
Endogenous cardiac glycosides, a new class of steroid hormones
W Schoner
EUROPEAN JOURNAL OF BIOCHEMISTRY (2002)
Endogenous ligand of α sodium pump, marinobufagenin, is a novel mediator of sodium chloride-dependent hypertension
OV Fedorova et al.
CIRCULATION (2002)
Changes in sodium or glucose filtration rate modulate expression of glucose transporters in renal proximal tubular cells of rat
S Vestri et al.
JOURNAL OF MEMBRANE BIOLOGY (2001)
Marinobufagenin, an endogenous α-1 sodium pump ligand, in hypertensive Dahl salt-sensitive rats
OV Fedorova et al.
HYPERTENSION (2001)
Glucose transporters: Structure, function and consequences of deficiency
GK Brown
JOURNAL OF INHERITED METABOLIC DISEASE (2000)
分享论文
